| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
78,530 |
31,225 |
$9.37M |
| 87634 |
|
62,155 |
24,100 |
$2.59M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,158 |
3,387 |
$498K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
813 |
328 |
$25K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
16 |
16 |
$2K |
| 99000 |
|
74 |
31 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
247 |
127 |
$1K |